금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Iran says no progress on interim peace deal with US — Reuters
The United States (US) and Iran remain at loggerheads over efforts to agree a permanent end to the ...
Robinhood slips 6% in second straight session of losses
Japanese Yen: Verbal intervention fails to move JPY against US Dollar – Scotiabank
Scotiabank’s Shaun Osborne and Eric Theoret note USD/JPY is little changed despite strong verbal intervention from Finance Minister Katayama, who warned of decisive action at any time. Markets remain ...
US Equity Markets End Lower as Oil Prices Climb on US-Iran Escalation
US equity indexes closed lower on Friday as crude oil prices jumped amid escalating attacks by the U
S&P 500 logs weekly decline as tech selloff weighs on markets
Chip stocks drag down Nasdaq for the week; PayPal soars on Stripe takeover bid
Why Intuitive Surgical Stock Plunged Today
Shares of the Maker of Robotic Surgical Tools Led S&P 500 Decliners on Friday
CN Energy Group. Inc. Receives Nasdaq Notice Regarding Minimum Bid Price Requirement
CN Energy Group. Inc. (NASDAQ: CNEY) ("CNEY" or the "Company") today that it has received a written notification from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") da ...
Why Tesla Might Not Merge With SpaceX After All
Tesla stock has been stuck for the past few months, supported by hopes for a SpaceX merger while the company’s progress on AI efforts remain opaque.
Trump threatens Canada with tariffs over wildfire smoke
Calvin B. Taylor Bankshares raises quarterly dividend by 7.9% to $0.41/share
US stocks sink this week, semiconductors walloped amid sell-off
US equities (^DJI, ^IXIC, ^GSPC) closed Friday's session in negative territory — led by the Nasdaq Composite's 1.4% drop — all three of the market indexes seeing weekly losses amid the recent sell-off ...
4DMT Announces New Employment Inducement Grants
EMERYVILLE, Calif., July 17, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted t ...